newsfilter
← Latest News
Business Wire·

Niagen Bioscience Increases Share Repurchase Program to $20 Million

Niagen Bioscience, Inc. (NASDAQ:NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors has authorized an